Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$53.09M-15.3%-$46.06M-9.1%-$42.22M+3.6%-$43.78M-44.1%-$30.39M+9.5%
$119K-36.4%$187K+335%$43K-67.4%$132K+3.1%$128K+10.3%
$10.15M+138%$4.27M+0.4%$4.25M-9.4%$4.69M+7.2%$4.38M-30.8%
-$45.99M-20.0%-$38.33M-11.0%-$34.53M-15.5%-$29.88M+32.1%-$43.98M-67.3%
$4.53M+103%-$162.18M-1,039%$17.27M-$45.08M+60.6%
$45.7M-78.6%$213.55M+520,759%$41K+102%-$2.52M-1,234%$222K-99.9%
$4.25M-$17.21M-$88.84M-186%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Olema Pharmaceuticals, Inc. generate?
Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
What is Olema Pharmaceuticals, Inc.'s free cash flow?
After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.
Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.